Details for New Drug Application (NDA): 012731
✉ Email this page to a colleague
NDA 012731 describes DECASPRAY, which is a drug marketed by Merck and is included in one NDA. Additional details are available on the DECASPRAY profile page.
The generic ingredient in DECASPRAY is dexamethasone. There are thirty-nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
The generic ingredient in DECASPRAY is dexamethasone. There are thirty-nine drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the dexamethasone profile page.
Summary for 012731
| Tradename: | DECASPRAY |
| Applicant: | Merck |
| Ingredient: | dexamethasone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 012731
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL;TOPICAL | Strength | 0.04% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
